Gastroenterology
Volume 138, Issue 2 , Pages 411-416.e2 , February 2010

State of Research in Pediatric Gastroenterology, Hepatology, and Nutrition: 2010 and Beyond

  • W. Allan Walker

      Affiliations

    • Harvard Medical School, Mucosal Immunology Laboratory, Massachusetts General Hospital for Children, Boston, Massachusetts
    • Corresponding Author InformationReprint requests Address requests for reprints to: W. Allan Walker, MD, Mucosal Immunology Laboratory, Massachusetts General Hospital, 114 13th Street (114-3503), Charlestown, Massachusetts 02129-4404
    • ,
  • Philip Sherman

      Affiliations

    • Division of Pediatric Gastroenterology and Nutrition, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Benjamin L. Shneider

      Affiliations

    • Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Mitchell Cohen

      Affiliations

    • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio
    • ,
  • John Barnard

      Affiliations

    • Nationwide Children's Hospital, Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University College of Medicine, Columbus, Ohio

References 

  1. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007;449:804–810
  2. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008;57:1605–1615
  3. Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota. PLos Biol. 2007;5:3177
  4. Reinhardt C, Reigstad CS, Backhed F. Intestinal microbiota during infancy and its implication for obesity. J Pediatr Gastroenterol Nutr. 2009;48:249–256
  5. Wang Y, Hoenig JD, Malin KJ, Qamar S, et al. 16SrRNA gene-based analysis of fecal micribiota from preterm infants with an without necrotizing enterocolitis. The ISME J. 2009;3:944–954

 Conflicts of interest The authors disclose the following: W. Allan Walker serves on the scientific advisory boards of, Dannon Company, Mead Johnson Nutritional Group, Wyeth Nutritional, and Yakult Company. Philip Sherman owns stock in Antibe Therapeutics; has a research contract with Institute Rosell Lallemand, Inc.; serves on the medical advisory boards of Abbott Nutritionals, Nestle Nutrition, and AstraZeneca; and serves on the educational advisory board of InSinc Consultants.

PII: S0016-5085(09)02195-7

doi: 10.1053/j.gastro.2009.12.034

Gastroenterology
Volume 138, Issue 2 , Pages 411-416.e2 , February 2010

Article Tools